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Abstract
AIM
To study differences of presentation, management, and 
prognosis of alcoholic hepatitis in Latinos compared to 
Caucasians. 
METHODS
We retrospectively screened 876 charts of Caucasian 
and Latino patients who were evaluated at Univer-
sity of California Davis Medical Center between 
1/1/2002-12/31/2014 with the diagnosis of alcoholic 
liver disease. We identified and collected data on 137 
Caucasians and 64 Latinos who met criteria for alcoholic 
hepatitis, including chronic history of heavy alcohol use, 
at least one episode of jaundice with bilirubin ≥ 3.0 or 
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coagulopathy, new onset of liver decompensation or 
acute liver decompensation in known cirrhosis within 
12 wk of last drink. 
RESULTS
The mean age at presentation of alcoholic hepatitis 
was not significantly different between Latinos and 
Caucasians. There was significant lower rate of overall 
substance abuse in Caucasians compared to Latinos 
and Latinos had a higher rate of methamphetamine 
abuse (12.5% vs  0.7%) compared to Caucasians. 
Latinos had a higher mean number of hospitalizations 
(5.3 ± 5.6 vs  2.7 ± 2.7, P  = 0.001) and mean 
Emergency Department visits (9.5 ± 10.8 vs  4.5 ± 4.1, 
P  = 0.017) for alcohol related issues and complications 
compared to Caucasians. There was significantly higher 
rate of complications of portal hypertension including 
gastrointestinal bleeding (79.7% vs  45.3%, P  < 0.001), 
spontaneous bacterial peritonitis (26.6% vs  9.5%, P  
= 0.003), and encephalopathy (81.2% vs  55.5%, P  = 
0.001) in Latinos compared to Caucasians.
CONCLUSION
Latinos have significant higher rates of utilization of 
acute care services for manifestations alcoholic hepatitis 
and complications suggesting poor access to outpatient 
care. 
Key words: Alcoholic hepatitis; Latino; Hispanic; 
Caucasian; Alcoholic liver disease
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: We conducted a retrospective chart review on 
Caucasian and Latino patients with alcoholic hepatitis. 
We showed that Latinos had significantly higher rates of 
gastrointestinal bleeding, encephalopathy, spontaneous 
bacterial peritonitis, recurrence of alcoholic hepatitis, 
and utilization of acute care services for alcohol related 
issues compared to Caucasians. However, the survival 
rates were not significantly different between Latinos 
and Caucasians. Our findings suggest that Latino 
patients have poor access to outpatient care and 
management of complications of portal hypertension.
Pinon-Gutierrez R, Durbin-Johnson B, Halsted CH, Medici V. 
Clinical features of alcoholic hepatitis in latinos and caucasians: 
A single center experience. World J Gastroenterol 2017; 
23(40): 7274-7282  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v23/i40/7274.htm  DOI: http://dx.doi.
org/10.3748/wjg.v23.i40.7274
INTRODUCTION
Alcoholism is estimated to cause 2.5 million deaths 
annually worldwide, and it represents 4% of all 
deaths[1]. Forty percent of all mortality from cirrhosis is 
attributed to alcoholic liver disease (ALD). ALD includes 
different clinical entities with different severity and 
prognosis, ranging from alcoholic fatty liver disease 
characterized by hepatic steatosis, to severe alcoholic 
hepatitis (AH), and ultimately alcoholic cirrhosis[1] with 
portal hypertension and its complications. Disparities 
exist in the incidence and severity of ALD among 
various racial and ethnic groups in the United States.
Ethnicity data from the National Center for Health 
Statistics for 1991-1997 showed greatest liver cirrhosis 
mortality among Latino men compared to Black 
and Caucasian men followed by Latina females[2]. A 
comprehensive discharge study of all patients with ALD 
in non-federal hospitals in Los Angeles County in 1999 
showed that ALD accounted for 1.2% of all deaths 
and was most prevalent in middle aged Latino men as 
compared to other ethnicities[3]. A more recent study 
showed that the Latino population in the United States 
has a higher incidence and more aggressive pattern of 
chronic liver diseases than the Caucasian population[4]. 
Longevity data from a multicenter Veteran Affairs 
cooperative study showed that the 5-year survival 
from active ALD was only 28% among Latino men 
compared to 40% in Caucasian men[5]. Among heavy 
alcohol drinkers, Latinos were 9.1 times more likely to 
have a 2-fold elevation in AST and GGT levels when 
compared to Caucasians[6], and Mexican American 
men are more likely to be heavy binge drinkers than 
Caucasians and African American men or Mexican 
American women[7]. A recent review highlights the 
linkage of excessive alcohol intake and dependence 
among Mexicans to the presence of functional SNPs in 
genes that regulate both alcohol craving mechanisms 
in the brain and alcohol metabolism in the liver[8]. 
In our own experience[9], Latino patients treated at 
UC Davis for ALD were significantly younger than 
Caucasians at the time of presentation and were 
more likely than Caucasian patients to present with 
AH or cirrhosis. Despite these well documented 
differences, there are no ethnic-specific data on 
the various manifestations of ALD. AH is the most 
severe manifestation of ALD is characterized by an 
inflammatory process of the liver with neutrophilic 
infiltration leading to ballooning degeneration of 
hepatocytes, hepatocyte necrosis, steatosis and 
presence of Mallory bodies. AH clinic presentation is 
associated with jaundice, fever, hepatomegaly, liver 
tenderness, encephalopathy, and gastrointestinal 
bleeding (GIB)[1]. The goal of the present study was to 
determine the clinical features of AH in Latino patients 
compared to Caucasian patients.
MATERIALS AND METHODS
We performed a single-center retrospective chart 
review of 137 Caucasian patients and 64 Latino 
patients older than 18 years old diagnosed with AH 
and who were seen at the University of California Davis 
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Hepatology Clinic or hospitalized at the University 
of California Davis Medical Center in Sacramento, 
California between 1/1/2002-12/31/2014. Of note, 
it is estimated that 83% of Latinos living in the 
Sacramento area are Mexican Americans (http://
quickfacts.census.gov/qfd/states/06/06067.html). We 
performed a chart review of 876 Caucasian and Latino 
patients with ICD9 codes for AH, alcoholic cirrhosis, 
ALD, and unspecified liver damage identify subjects 
with AH of each group. When possible, we applied the 
NIAAA Alcoholic Hepatitis Consortia criteria[10] with 
few modifications given the retrospective nature of 
the study: (1) chronic history of heavy alcohol use; 
(2) at least one episode of jaundice with bilirubin ≥ 
3 or coagulopathy with INR ≥ 1.2 (modification); 
(3) new onset of liver decompensation; (4) diagnosis 
acute AH per ICD-9 code on known cirrhosis; and 
(5) within 12 wk (modification) of last drink and 
where no other causes of liver decompensation were 
identified. Otherwise, ICD9 codes for AH were applied 
to ensure the highest number of subjects was included 
in the study. We excluded patients with known active 
hepatitis B (positive HBsAg and Hepatitis B viral load > 
20,000 IU/mL) and active hepatitis C (positive HCV Ab 
and HCV viral load > 615 IU/mL). 
We used the demographics section of the electronic 
medical record and/or from history and physical 
examination notes to identify our research population, 
ethnicity, gender, and age of onset of AH. We defined 
the drinking patterns as follow: moderate drinking 
was defined as no more than four drinks per day, or 
14 drinks per week for men, and no more than three 
drinks per day, or 7 drinks per week for women, and 
heavy drinking defined as 15 or more drinks per week, 
or four drinks in a day, for men or, more than seven 
drinks per week, or three drinks a day for women. We 
defined binge drinking as five or more drinks for male 
or 4 or more drinks in female in about 2 h on multiple 
occasions. We also gathered drinking duration occurred 
in our patient population. We included data pertaining 
to body mass index (BMI) and whether subjects had a 
diagnosis of metabolic syndrome and diabetes mellitus 
(DM). We recorded the development of complications 
associated with AH and/or portal hypertension including 
GIB, encephalopathy, spontaneous bacterial peritonitis 
(SBP), and presence of other infections, pancreatitis, 
development of acute kidney injury (AKI) and/or 
hepatorenal syndrome, disseminated intravascular 
coagulopathy (DIC), and hepatocellular carcinoma. We 
recorded intensive care unit (ICU) admission, length 
of ICU stay, development of respiratory failure, and 
length of hospital stay, and we determined the number 
of emergency room visits and hospitalizations for 
alcohol related morbidity. 
We made the distinction of AH without known history 
of cirrhosis and AH with known cirrhosis and recorded 
the number of times a patient met our criteria for AH. 
To assess severity of AH, we calculated the Discriminant 
Function (DF) [4.6 × (Pt's PT - Control PT) + TBili]. If ≥ 
32, it is considered severe AH[11] with related increased 
risk of mortality[12]. We determined Glasgow score for 
AH, Model for End-Stage Liver Disease (MELD) score, 
and Child-Turcotte-Pugh class. We collected data on 
modality of medical treatment of severe AH (supportive 
care, steroids, pentoxifylline including their duration and 
doses). Finally, we collected survival data that included 
total survival days after episode of AH (total number of 
days since date of AH to last day to be alive or seen at 
the UC Davis Medical Center or clinic).
Statistical analyses 
Categorical variables were compared between ethnicities 
using χ 2 tests, followed by examination of adjusted 
residuals in the case of a significant test. Continuous 
variables were compared between ethnicities using 
t-tests, with duration data and lab data log-transformed 
prior to testing. Survival was compared between 
ethnicities using log rank tests. 
The effects of subject disease characteristics and 
treatment on overall survival were analyzed using Cox 
proportional hazards models. Analyses were conducted 
for all subjects and separately for each ethnicity. All 
analyses were adjusted for age, sex, BMI, and, for 
analyses in all subjects, ethnicity. Analyses were 
conducted using R, version 3.3.1 (R Core Team, 2016).
RESULTS
The mean age at presentation for all patients was 
48.6 ± 10.4 years and was not significantly different 
between Latinos and Caucasians. Among men, there 
was a marginally significant higher proportion of male 
Latino subjects with AH compared to Caucasians 
subjects (71.9% vs 56.2%, P = 0.049). There 
were no significant differences between Latinos and 
Caucasians in BMI, presence of DM, or metabolic 
syndrome (Table 1). The mean duration of drinking 
was longer in Latinos compared to Caucasians (24.3 
± 11.0 years vs 20.5 ± 12.7 years, P = 0.027). There 
were no significant differences between Latinos and 
Caucasians regarding pattern of drinking or daily mean 
average number of alcoholic drinks (Table 1). Latinos 
and Caucasians presented different patterns of non-
alcoholic substance abuse. Caucasians had significant 
higher rates of having no history of substance abuse 
(73.0% vs 57.8%), whereas more Latinos had a 
history of methamphetamine abuse (12.5% vs 0.7%) 
and a remote history of substance abuse (9.4% vs 
4.4%) than would be expected under homogeneity of 
variance (P = 0.003) (Table 1).
Latinos had about twice the number of emergency 
department (ED) and hospitalizations visits due 
to alcohol intoxication and alcohol related issues 
compared to Caucasians (Figures 1 and 2). There was 
no significant difference in the mean length of hospital 
stay between Latinos (52 subjects admitted out of 64) 
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AH without history of cirrhosis (76.6% vs 68.6%) and 
with history of cirrhosis (23.4% vs 31.4%) (P = 0.321). 
The mean DF score of the whole group was 46.7 ± 33.9 
and there was no significant difference in prevalence 
of severe AH, as determined by DF > 32, between 
Latinos and Caucasians, mean MELD score, and 
and Caucasians (111 admitted out of 137) admitted 
to the hospital with AH and there was no significant 
difference between Latinos and Caucasians requiring 
ICU admission and length of ICU stay in days (Table 2). 
There were no significant differences in the pro-
portions of Latinos and Caucasians who presented with 
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Figure 2  Hospitalizations for alcohol-related issues. There was a significant 
difference in the mean number of hospital admissions for alcohol related issues 
between ethnicities. Latinos had a higher mean number of hospital admissions 
for alcohol related issues compared to Caucasians (5.3 ± 5.6 vs 2.7 ± 2.7 
admissions, P = 0.001).
Caucasian (n  = 137) Latino (n  = 64) All Patients (n  = 201) P  value
Age of presentation with AH (yr) 0.082
   mean ± SD 49.5 (10.4) 46.8 (10.1)        48.6 (10.4)
Sex 0.049
   Male 77 (56.2)  46 (71.9)    123 (61.2)
   Female   60 (43.8)  18 (28.1)      78 (38.8)
BMI 0.167
   mean ± SD    28.1 (5.9)   29.4 (6.2)    28.5 (6)
DM 0.061
   No 105 (76.6) 41 (64.1)    146 (72.6)
   Yes  25 (18.2) 20 (31.2)      45 (22.4)
   Unknown  7 (5.1) 3 (4.7) 10 (5)
Metabolic syndrome 0.405
   No 37 (27) 13 (20.3)     50 (24.9)
   Yes   53 (38.7) 28 (43.8)      81 (40.3)
   Unknown   47 (34.3) 23 (35.9)      70 (34.8)
Duration of drinking (yr) 0.027
   mean ± SD   20 (12.7)  24.3 (11)         21.6 (12.3)
Pattern of drinking 0.283
   Heavy drinking   5 (3.6) 0      5 (2.5)
   Binge drinking 130 (94.9)    64 (100.0)    194 (96.5)
   Unknown   2 (1.5) 0      2 (1.0)
Number of drinks/d 0.093
   mean ± SD     13.9 (10.9)   16.1 (7.2)       14.6 (9.9)
   None 100 (73.0)   37 (57.8)    137 (68.2)
   Cocaine   2 (1.5) 0      2 (1.0)
   Heroin   1 (0.7) 0      1 (0.5)
   Methamphetamine   1 (0.7)    8 (12.5)      9 (4.5)
   Marijuana   9 (6.6)  3 (4.7)    12 (6.0)
   Other   2 (1.5) 0      2 (1.0)
   Polysubstance abuse  10 (7.3)    9 (14.1)    19 (9.5)
   Remote history   6 (4.4)  6 (9.4)    12 (6.0)
   Unknown   6 (4.4)   1 (1.6)      7 (3.5)
Table 1  Patient Characteristics n  (%)
AH: Alcoholic hepatitis; BMI: Body mass index; DM: Diabetes mellitus.
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Figure 1  Emergency department visits for alcohol-related issues. There 
was a significant difference in the mean number of ED visits for alcohol related 
issues between ethnicities. Latinos had a significant higher mean number of ED 
visits for alcohol related issues compared to Caucasians (9.5 ± 10.8 vs 4.1 ± 4.1 
ED visits, P ≤ 0.001). ED: Emergency department.
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initial mean Glasgow score for AH (Table 3). Among 
patients who received medical treatment for severe 
AH (Latinos n = 15 and Caucasians n = 37), patients 
from both ethnicities were treated similarly with 
similar proportions of patients treated with steroids, 
pentoxyfilline or combination of both (Table 3). There 
was no significant difference in the Lille score after 7 d 
of treatment between Latinos (n = 14) and Caucasians 
(n = 35) (Table 3). 
Latinos and Caucasians admitted with AH presented 
a similar rate of complications including respiratory 
failure, acute pancreatitis, AKI, hepatorenal syndrome, 
and DIC (Table 4). However Latinos had higher rates 
of portal hypertension complications including overall 
GIB (Figure 3A), SBP (Figure 3B), encephalopathy 
(Figure 3C), and recurrence of AH (Figure 3D) 
compared to Caucasians. Despite these higher rates 
of complications, Latinos presented a longer median 
survival compared to Caucasians but the difference 
was not significant (12.1 vs 4.6 years, P = 0.055) 
(Figure 4). 
Table 5 shows results of Cox proportional hazards 
analysis of overall survival. In the analysis of all subjects, 
after adjusting for age, BMI, sex, and ethnicity, a higher 
MELD score, a Child-Turcotte-Pugh score of C, an 
initial Maddrey score > 32, abnormal renal function, 
and presence of hepatorenal syndrome were all 
associated with significantly higher hazards of death. 
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Figure 3  Clinical manifestations of alcoholic hepatitis. There was a significant difference in the proportion of patients who experienced GIB, SBP, encephalopathy, 
and recurrence of AH between ethnicities. A: A significant higher proportion of Latinos experienced GIB compared to Caucasians (79.7% vs 45.3%, P < 0.001); 
B: A significantly higher proportion of Latinos experienced SBP compared to Caucasians (26.6% vs 9.5%, P = 0.003); C: A significant higher proportion of Latinos 
experienced encephalopathy compared to Caucasians (81.2% vs 55.5%, P = 0.001); D: A higher proportion of Latinos had recurrent AH compared to Caucasians (32.8% 
vs 11.7%, P = 0.005). AH: Alcoholic hepatitis; GIB: Gastrointestinal bleeding; SBP: Spontaneous bacterial peritonitis.
Caucasian Latino All patients P  value
Hospitalization duration (in days) 111 52 163 0.239
   mean ± SD   14.4 (12.8)   13.8 (15.9)        14.2 (13.8)
ICU admission 111 52 163 0.756
   Yes 39 (35.1) 17 (32.7)    56 (34.4)
   No 72 (64.9) 35 (67.3)   107 (65.6)
ICU stay (in days)  39 15     54 0.587
   mean ± SD   7.7 (9.9)    12.2 (16.6)         8.9 (12.1)
Table 2  Level of care n  (%)
111 out of the 137 Caucasians and 52 out of 64 Latino Subjects were admitted to the hospital for management of alcoholic hepatitis. The other Caucasians 
and Latino patients were seen in the ED or outpatient setting. ICU: Intensive care unit.
Pinon-Gutierrez R et al. Presentation, management and prognosis of alcoholic hepatitis
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In Latinos, after adjusting for age, BMI, and sex, a 
higher MELD score, a Child-Turcotte-Pugh score of C, 
an initial Glasgow score above 9, and the presence 
of hepatorenal syndrome were associated with 
significantly higher hazards of death. In Caucasian 
subjects, after adjusting for age, BMI, and sex, a 
higher MELD score, a Child-Turcotte-Pugh score of C, 
abnormal renal function, and presence of hepatorenal 
syndrome were associated with significantly higher 
hazards of death. 
 
DISCUSSION
AH is an acute hepatic inflammation that usually occurs 
in heavy drinkers and is associated with significant 
morbidity and mortality in severe cases of up to 
30%-50% at 6 mo[13]. Several previous studies indicated 
that Latino patients with ALD had earlier onset of 
disease and poorer prognosis compared to Caucasians[9] 
but specific data on ALD subtypes are lacking. The goal 
of the present study was to focus on a sample of Latino 
patients with AH followed at UC Davis Medical Center in 
Sacramento, California and describe any similarities and 
differences of AH in comparison to Caucasian patients, 
with the ultimate goal to identify specific needs and 
potential gaps in the care of this population. First, 
Latinos and Caucasians appeared to differ primarily 
in the duration of alcohol drinking, which was longer 
for the Latinos, and methamphetamine use, which 
was also more prevalent in Latinos. These findings are 
corroborated by previous large epidemiological studies 
showing that Mexican migrants in California presented 
a high prevalence of methamphetamine use associated 
with alcohol use and other psychiatric issues[14]. The 
two groups received similar medical treatment once 
admitted for severe AH. However, Latinos appear to 
present more frequently with manifestations of severe 
portal hypertension in association with more frequent 
utilization of the acute services but not ICU. Overall, 
these disparities did not seem to affect the survival of 
our studied Latino population. Several clinical studies 
Caucasian Latino All patients P  value
Type of AH 137 64 201 0.321
   Acute AH with no history of cirrhosis 94 (68.6)   49 (76.6)   143 (71.1)
   AH on chronic cirrhosis 43 (31.4)   15 (23.4)     58 (28.9)
DF score at day 0 137 64 201 0.794
   mean ± SD     47.7 (37.2)      46.6 (22.1)         47.3 (33.1)
   DF < 32 44 (32.1)   12 (18.8)      56 (27.9)
   DF > 32 93 (67.9)   52 (81.2)    145 (72.1)
Initial MELD score 137 64 201 0.661
   mean ± SD 21.1 (7)     21.6 (6.7)       21.3 (6.9)
   < 9   2 (1.5) 0  2 (1)
   10-19  61 (44.5)   30 (46.9)     91 (45.3)
   20-29 53 (38.7)   25 (39.1)     78 (38.8)
   30-39 19 (13.9)    9 (14.1)     28 (13.9)
   > 40 2 (1.5) 0     2 (1.0)
Glasgow AH score at day 0 0.991
   mean ± SD      7.5 (1.6)     7.4 (1.5)        7.5 (1.6)
   < 9 109 (71.7)   53 (69.7)   162 (71.1)
   > 9   43 (28.3)   23 (30.3)     66 (28.9)
Type of treatment   37 15   52 0.862
   Steroids   16 (11.7)     8 (12.5)     24 (11.9)
   Pentoxifylline 13 (9.5)   4 (6.2)   17 (8.5)
   Both   8 (5.8)   3 (4.7)    11 (5.5)
Lille score after 7 d 0.829
   < 0.45  18 (13.1)    8 (12.5)   26 12.9)
   > 0.45  17 (12.4)  6 (9.4)     23 (11.4)
Table 3  Type of alcoholic hepatitis, parameters of liver injury and treatment n  (%)
AH: Alcoholic hepatitis; MELD: Model for end stage liver disease; DF: Maddrey discriminant function is defined as DF = 4.6 x [prothrombin time (s) - 
control prothrombin time (s)] + (serum bilirubin in mg/dL)[11].
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Figure 4  Survival by ethnicity. There was no significant difference in the 
median survival between ethnicities as shown on Kaplan-Meier Plot. The 
median survival in years between Latinos and Caucasians was not significantly 
different (12.1 yr vs 4.6 yr, P = 0.055).
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indicate that Latinos develop more severe liver diseases 
than other ethnicities and this has been confirmed in 
common conditions including ALD[9,15], non-alcoholic 
steatohepatitis[16], and chronic hepatitis C[17,18] or more 
rare diseases including primary biliary cholangitis[19]. 
In addition, Latinos might have an increased risk of 
hepatocellular carcinoma[20]. Ethnic matching between 
patients with alcohol-related injury or alcohol problems 
improved the effectiveness of the brief alcohol 
intervention on drinking outcomes of Latino patients, 
especially the foreign-born and less acculturated[21]. Our 
data indicate that, at least in our center, Latinos with 
AH are receiving similar inpatient medical management 
compared to Caucasians. It should be noted that only 
a small number of patients received treatment for 
severe AH during the studied period. This could be 
Caucasian Latino All patients P  value
Development of respiratory failure 137 64 201 0.687
   Yes 13 (9.5)    8 (12.5)     21 (10.4)
   No 124 (90.5)  56 (87.5)   180 (89.6)
Development of acute pancreatitis 0.413
   No 110 (80.3)  52 (81.2) 162 (80.6)
   Yes 13 (9.5)  3 (4.7)  16 (8.0)
   Unknown   14 (10.2)    9 (14.1)    23 (11.4)
Development of AKI 0.520
   Yes   33 (24.1)  19 (29.7)    52 (25.9)
   No 104 (75.9)  45 (70.3)  149 (74.1)
Hepatorenal syndrome 0.328
   No 119 (86.9)  60 (93.8)   179 (89.1)
   Yes, type 1    15 (10.9)   3 (4.7)   18 (9.0)
   Yes, type 2    3 (2.2)    1 (1.6)     4 (2.0)
Development of DIC 0.497
   Yes    3 (2.2) 0     3 (1.5)
   No 89 (65)   50 (78.1)   139 (69.2)
   Unknown    45 (32.8)   14 (21.9)     59 (29.4)
Table 4  Complications associated with alcoholic hepatitis n  (%)
AKI: Acute kidney injury; DIC: Disseminated intravascular coagulation.
All subjects Caucasian subjects Latino subjects
HR (95%CI) P  value HR (95%CI) P  value HR (95%CI) P  value
History of GI bleeding: yes vs no 0.79
(0.49, 1.28)
0.339 0.91
(0.53, 1.54)
0.718 0.39
(0.09, 1.72)
0.213
History of SBP: yes vs no 0.95
(0.50, 1.80)
0.874 0.86
(0.37, 2.01)
0.727 0.98
(0.37, 2.62)
0.97
ICU Admission: yes vs No 1.32
(0.80, 2.19)
0.278 1.42
(0.79, 2.56)
0.237 1.31
(0.45, 3.81)
0.618
MELD score2 1.88
(1.39, 2.55)
< 0.001 1.86
(1.29, 2.69)
0.001 2.15
(1.19, 3.87)
0.011
Child-turcotte-pugh score: C vs A or B 2.85
(1.62, 5.00)
< 0.001 2.62
(1.36, 5.07)
0.004 4.3
(1.24, 14.9)
0.021
Initial glasgow score: > 9 vs < 9 1.86
(1.18, 2.93)
0.008 1.6
(0.93, 2.74)
0.091 2.91
(1.21, 6.97)
0.017
Initial maddrey score: > 32 vs < 32 2.41
(1.29, 4.49)
0.006 1.82
(0.95, 3.50)
0.072 3 3
Treatment with steroids: yes vs no 1.63
(0.89, 2.98)
0.113 1.68
(0.81, 3.51)
0.164 2.05
(0.61, 6.88)
0.247
Duration of treatment with steroids: ≥ 28 d vs < 28 d 2.23
(0.66, 7.58)
0.198 5.28
(0.69, 40.5)
0.110 1.03
(0.01, 83.3)
0.988
Renal function: CKD 1 or higher vs CKD 0 7.43
(2.74, 20.1)
< 0.001 7.74
(2.8, 21.4)
< 0.001 3 3
Hepatorenal syndrome: yes vs no 7.07 < 0.001 7.77 < 0.001 5.65 0.006
(3.95, 12.7) (3.92, 15.4) (1.66, 19.2)
Table 5  Cox proportional hazards analyses of overall survival by subject characteristics1
1A separate analysis was conducted for each risk factor shown. All analyses were adjusted for age, sex, BMI, and, for analyses in all subjects, ethnicity; 
2Change in hazard of death for 10 point increase in actual MELD score; 3Not enough data to analyze. GI bleeding: Gastrointestinal bleeding; SBP: 
Spontaneous bacterial peritonitis; ICU: Intensive care unit; MELD: Model for end stage liver disease; CKD: Chronic kidney disease.
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related to the presence of contraindications to the use 
of steroids (for example active infections or GIB) or to 
the lack of proper diagnosis of severe AH by providers. 
The main issue regards the long term management 
of the complications of portal hypertension. Previous 
published data have shown that Latinos are more 
likely to visit the ED and are more often admitted 
through the ED for alcohol related issues[22]. Similarly, 
our study showed that Latinos present more frequently 
at the ED and are hospitalized more often compared 
to Caucasians for alcohol related issues, but also 
present more frequently severe complications of 
portal hypertension. This suggests a poor outpatient 
management of chronic complications of liver 
disease and inadequate access or use of outpatient 
clinics to receive preventive measures, including 
GIB prophylaxis with upper endoscopies and beta 
blockers, encephalopathy prophylaxis with lactulose, 
or prophylaxis with SBP when indicated. We did not 
observe any difference in survival between the two 
subpopulations and this may be in contradiction with 
the data showing worse outcome for Latinos with 
ALD. It is also interesting to note that the overall 
Latino population has better survival rate compared to 
Caucasians[23]. Our data reflect a small population in 
a highly diverse urban area but this initial data should 
help in identifying some of the major challenges 
in the care of underserved populations. Given the 
retrospective nature of the data collection and given 
the fact that is based on single center experience, we 
could not identify the actual background of the Latino 
population, which could be very heterogeneous. 
This single retrospective study did not confirm 
previous findings that Latinos developed AH at earlier 
age compared to Caucasians[9]. In fact, there was no 
significant difference between the ages of presentation 
of AH between Latinos and Caucasians. Our study also 
suggested that there is no difference in the severity 
of AH at presentation and management between the 
ethnicities. On the other hand, this study showed 
Latinos had higher rates of complications associated 
with AH which include GIB, encephalopathy, and 
SBP. Latinos also had higher rates of AH recurrence. 
Interestingly, there was no significant difference in the 
overall mortality between ethnicities. In fact, Latinos 
may have better survival than Caucasians even though 
this is was not statistically significant in our study. 
Future research is needed to elucidate the effects of 
alcohol on Latinos and the predisposing factor that 
lead to the development of AH as well as the study of 
measures that can improve access to care and adequate 
outpatient follow-up for this underserved population.
ATRICLE HIGHLIGHTS
Research background
There are well known differences in the presentation of alcoholic liver disease 
(ALD) between Caucasian and Mexican-American patients. However, there are 
no ethnic-specific data on alcoholic hepatitis. 
Research motivation
Alcoholic hepatitis is the most severe manifestation of ALD and is characterized by 
an inflammatory process of the liver with neutrophilic infiltration leading to ballooning 
degeneration of hepatocytes, hepatocyte necrosis, steatosis and presence of Mallory 
bodies. Alcoholic hepatitis clinic presentation is associated with jaundice, fever, 
hepatomegaly, liver tenderness, encephalopathy, and gastrointestinal bleeding. Ultimately, 
alcoholic hepatitis is characterized by a high risk of mortality. Latino and Caucasian patients 
with ALD and alcoholic hepatitis may have different progression and prognosis compared to 
other ethnicities.
Research objectives 
The goal of the present study was to determine the clinical features of alcoholic 
hepatitis in Latino patients compared to Caucasian patients. The overarching 
goal is to optimize the care of patients of different ethnicities and identify their 
challenges when accessing medical care in the United States.
Research methods
The authors conducted a single-center retrospective chart review of 137 Caucasian patients 
and 64 Latino patients older than 18 years old diagnosed with alcoholic hepatitis. We 
collected extensive clinical data on their diagnosis, treatment, and outcome.
Research results
The major finding was a significantly higher rate of complications of portal hypertension 
including gastrointestinal bleeding, spontaneous bacterial peritonitis, and encephalopathy in 
Latino compared to Caucasian patients with alcoholic hepatitis. Despite these differences, the 
two ethnic groups did not present differences in survival. Future studies should prospectively 
confirm these findings in larger populations. 
Research conclusions
According to our results, Latinos with alcoholic hepatitis presents with more 
severe complications of alcoholic hepatitis and appear to have limitations in 
access to medical treatment of long term complications of portal hypertension. 
Efforts should be made to ensure improved access to care and compliance.
REFERENCES
1 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. 
World J Gastroenterol 2014; 20: 2143-2158 [PMID: 24605013 
DOI: 10.3748/wjg.v20.i9.2143]
2 Stinson FS, Grant BF, Dufour MC. The critical dimension of 
ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp 
Res 2001; 25: 1181-1187 [PMID: 11505049 DOI: 10.1111/
j.1530-0277.2001.tb02333.x]
3 Tao N, Sussman S, Nieto J, Tsukamoto H, Yuan JM. Demographic 
characteristics of hospitalized patients with alcoholic liver 
disease and pancreatitis in los angeles county. Alcohol Clin Exp 
Res 2003; 27: 1798-1804 [PMID: 14634496 DOI: 10.1097/01.
ALC.0000095862.30777.D9]
4 Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver 
disease in the Hispanic population of the United States. Clin 
Gastroenterol Hepatol 2011; 9: 834-841; quiz e109-10 [PMID: 
21628000 DOI: 10.1016/j.cgh.2011.04.027]
5 Mendenhall CL, Gartside PS, Roselle GA, Grossman CJ, Weesner 
RE, Chedid A. Longevity among ethnic groups in alcoholic liver 
disease. Alcohol Alcohol 1989; 24: 11-19 [PMID: 2645888 DOI: 
10.1093/oxfordjournals.alcalc.a044862]
6 Stewart SH. Racial and ethnic differences in alcohol-associated 
aspartate aminotransferase and gamma-glutamyltransferase 
elevation. Arch Intern Med 2002; 162: 2236-2239 [PMID: 
12390068 DOI: 10.1001/archinte.162.19.2236]
7 Flores YN ,  Yee HF Jr, Leng M, Escarce JJ, Bastani R, 
Salmerón J, Morales LS. Risk factors for chronic liver disease 
Pinon-Gutierrez R et al. Presentation, management and prognosis of alcoholic hepatitis
 ATRICLE HIGHLIGHTS
7282 October 28, 2017|Volume 23|Issue 40|WJG|www.wjgnet.com
in Blacks, Mexican Americans, and Whites in the United States: 
results from NHANES IV, 1999-2004. Am J Gastroenterol 
2008; 103: 2231-2238 [PMID: 18671818 DOI: 10.1111/
j.1572-0241.2008.02022.x]
8 Roman S, Zepeda-Carrillo EA, Moreno-Luna LE, Panduro A. 
Alcoholism and liver disease in Mexico: genetic and environmental 
factors. World J Gastroenterol 2013; 19: 7972-7982 [PMID: 
24307790 DOI: 10.3748/wjg.v19.i44.7972]
9 Levy R, Catana AM, Durbin-Johnson B, Halsted CH, Medici 
V. Ethnic differences in presentation and severity of alcoholic 
liver disease. Alcohol Clin Exp Res 2015; 39: 566-574 [PMID: 
25702770 DOI: 10.1111/acer.12660]
10 Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, 
Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, 
Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G; NIAAA Alcoholic 
Hepatitis Consortia. Standard Definitions and Common Data 
Elements for Clinical Trials in Patients With Alcoholic Hepatitis: 
Recommendation From the NIAAA Alcoholic Hepatitis Consortia. 
Gastroenterology 2016; 150: 785-790 [PMID: 26921783 DOI: 
10.1053/j.gastro.2016.02.042]
11 Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey 
E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. 
Gastroenterology 1978; 75: 193-199 [PMID: 352788]
12 Thursz MR, Richardson P, Allison M, Austin A, Bowers M, 
Day CP, Downs N, Gleeson D, MacGilchrist A, Grant A, Hood 
S, Masson S, McCune A, Mellor J, O’Grady J, Patch D, Ratcliffe 
I, Roderick P, Stanton L, Vergis N, Wright M, Ryder S, Forrest 
EH; STOPAH Trial. Prednisolone or pentoxifylline for alcoholic 
hepatitis. N Engl J Med 2015; 372: 1619-1628 [PMID: 25901427 
DOI: 10.1056/NEJMoa1412278]
13 Jinjuvadia R, Liangpunsakul S; Translational Research and 
Evolving Alcoholic Hepatitis Treatment Consortium. Trends 
in Alcoholic Hepatitis-related Hospitalizations, Financial 
Burden, and Mortality in the United States. J Clin Gastroenterol 
2015;  49 :  506-511  [PMID:  25198164 DOI:  10 .1097/
MCG.0000000000000161]
14 Hernández MT, Sanchez MA, Ayala L, Magis-Rodríguez 
C, Ruiz JD, Samuel MC, Aoki BK, Garza AH, Lemp GF. 
Methamphetamine and cocaine use among Mexican migrants in 
California: the California-Mexico Epidemiological Surveillance 
Pilot. AIDS Educ Prev 2009; 21: 34-44 [PMID: 19824833 DOI: 
10.1521/aeap.2009.21.5_supp.34]
15 Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of 
alcohol-related liver and pancreatic disease in the United States. 
Arch Intern Med 2008; 168: 649-656 [PMID: 18362258 DOI: 
10.1001/archinte.168.6.649]
16 Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras 
M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver 
disease and nonalcoholic steatohepatitis among a largely middle-
aged population utilizing ultrasound and liver biopsy: a prospective 
study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 
DOI: 10.1053/j.gastro.2010.09.038]
17 Kallwitz ER, Layden-Almer J, Dhamija M, Berkes J, Guzman 
G, Lepe R, Cotler SJ, Layden TJ. Ethnicity and body mass index 
are associated with hepatitis C presentation and progression. Clin 
Gastroenterol Hepatol 2010; 8: 72-78 [PMID: 19686868 DOI: 
10.1016/j.cgh.2009.08.009]
18 Verma S, Bonacini M, Govindarajan S, Kanel G, Lindsay KL, 
Redeker A. More advanced hepatic fibrosis in hispanics with 
chronic hepatitis C infection: role of patient demographics, 
hepatic necroinflammation, and steatosis. Am J Gastroenterol 
2006; 101: 1817-1823 [PMID: 16790034 DOI: 10.1111/
j.1572-0241.2006.00682.x]
19 Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic 
VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini 
M, Combes B; PUMPS Group. Differences between Caucasian, 
African American, and Hispanic patients with primary biliary 
cirrhosis in the United States. Hepatology 2007; 46: 769-775 
[PMID: 17654740 DOI: 10.1002/hep.21759]
20 El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. 
Epidemiology of hepatocellular carcinoma in Hispanics in the 
United States. Arch Intern Med 2007; 167: 1983-1989 [PMID: 
17923599 DOI: 10.1001/archinte.167.18.1983]
21 Field C, Caetano R. The role of ethnic matching between patient 
and provider on the effectiveness of brief alcohol interventions 
with Hispanics. Alcohol Clin Exp Res 2010; 34: 262-271 [PMID: 
19951297 DOI: 10.1111/j.1530-0277.2009.01089.x]
22 May FP, Rolston VS, Tapper EB, Lakshmanan A, Saab S, 
Sundaram V. The impact of race and ethnicity on mortality and 
healthcare utilization in alcoholic hepatitis: a cross-sectional 
study. BMC Gastroenterol 2016; 16: 129 [PMID: 27724882 DOI: 
10.1186/s12876-016-0544-y]
23 Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by 
Hispanic status in the United States. JAMA 1993; 270: 2464-2468 
[PMID: 8031341 DOI: 10.1001/jama.1993.03510200070034]
P- Reviewer: Kamimura K, Skrypnyk IN, Xu CF    S- Editor: Wei LJ 
L- Editor: A    E- Editor: Ma YJ
Pinon-Gutierrez R et al. Presentation, management and prognosis of alcoholic hepatitis
                                      © 2017 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.f6publishing.com/helpdesk
http://www.wjgnet.com
I S S N  1 0  0 7  -   9  3 2  7
9    7 7 1 0  07   9 3 2 0 45
4   0
